Haleon plc
HLN
株式のランク
#13688
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
株価
$5.12
時価総額
$450.47M
変化（1日）
0.72%
変化（1年）
8.74%
国
GB
取引 Haleon plc (HLN)
カテゴリー
Healthcare
の時価総額 Haleon plc(HLN)
時価総額: $450.47M
October 2026時点で、Haleon plc の時価総額は $450.47M です。これは、当社のデータによると、Haleon plc が世界で13688th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Haleon plc の時価総額の履歴（2022 から 2026 まで）
